Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Renal relapse has known to be a poor prognostic factor in patients with lupus nephritis (LN), but there were few studies that identified the risk factors of renal relapse in real world. We conducted this study based on 35-years of experience at a single center to find out predictors of renal relapse in Korean patients with LN after achieving complete response (CR). Methods: We retrospectively analyzed the clinical, laboratory, pathologic and therapeutic parameters in 296 patients of LN who reached CR. The cumulative risk and the independent risk factors for renal relapse were examined by Kaplan-Meier methods and Cox proportional hazards regression analyses, respectively. Results: The median follow-up period from CR was 123 months. Renal relapse had occurred in 157 patients. Renal relapse occurred in 38.2%, 57.6% and 67.9% of patients within 5-, 10-, and 20-year, respectively. The age at diagnosis of SLE and LN were significantly younger, and the proportions of severe proteinuria and serum hypoalbuminemia were higher in patients with renal relapse. Interestingly, the proportion of receiving cytotoxic maintenance treatment was higher in patients with renal relapse. In Cox proportional hazards regression analyses, only young-age onset of LN (by 10 years, HR = 0.779, p = 0.007) was identified to independent predictor of renal relapse. Conclusions: Young-age onset of LN was only independent predictor and the patients with severe proteinuria and serum hypoalbuminemia also tended to relapse more, despite of sufficient maintenance treatment. Studies on more effective maintenance treatment regimens and duration are needed to reduce renal relapse.
Abstract
Background/Aims: Renal relapse has known to be a poor prognostic factor in patients with lupus nephritis (LN), but there were few studies that identified the risk factors of renal relapse in real world. We conducted this study based on 35-years of experience at a single center to find out predictors of renal relapse in Korean patients with LN after achieving complete response (CR). Methods: We retrospectively analyzed the clinical, laboratory, pathologic and therapeutic parameters in 296 patients of LN who reached CR. The cumulative risk and the independent risk factors for renal relapse were examined by Kaplan-Meier methods and Cox proportional hazards regression analyses, respectively. Results: The median follow-up period from CR was 123 months. Renal relapse had occurred in 157 patients. Renal relapse occurred in 38.2%, 57.6% and 67.9% of patients within 5-, 10-, and 20-year, respectively. The age at diagnosis of SLE and LN were significantly younger, and the proportions of severe proteinuria and serum hypoalbuminemia were higher in patients with renal relapse. Interestingly, the proportion of receiving cytotoxic maintenance treatment was higher in patients with renal relapse. In Cox proportional hazards regression analyses, only young-age onset of LN (by 10 years, HR = 0.779, p = 0.007) was identified to independent predictor of renal relapse. Conclusions: Young-age onset of LN was only independent predictor and the patients with severe proteinuria and serum hypoalbuminemia also tended to relapse more, despite of sufficient maintenance treatment. Studies on more effective maintenance treatment regimens and duration are needed to reduce renal relapse.
참고문헌 (48)
- Fasano S, "Precision medicine in systemic lupus erythematosus", Nat Rev Rheumatol, 19, pp.331~342 (2023)
- Hocaoǧlu M, "Incidence, prevalence, and mortality of lupus nephritis : a population-based study over four decades using the lupus midwest network", Arthritis Rheumatol, 75, pp.567~573 (2023)
- Danila MI, "Renal damage is the most important predictor of mortality within the damage index : data from LUMINA LXIV, a multiethnic US cohort", Rheumatology(Oxford), 48, pp.542~545 (2009)
- Maroz N, "Lupus nephritis and end-stage kidney disease", Am J Med Sci, 346, pp.319~323 (2013)
- Yap DY, "Survival analysis and causes of mortality in patients with lupus nephritis", Nephrol Dial Transplant, 27, pp.3248~3254 (2012)
- Moroni G, ""Nephritic flares"are predictors of bad long-term renal outcome in lupus nephritis", Kidney Int, 50, pp.2047~2053 (1996)
- Mosca M, "Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis", Kidney Int, 61, pp.1502~1509 (2002)
- El Hachmi M, "Relapses of lupus nephritis : incidence, risk factors, serology and impact on outcome", Lupus, 12, pp.692~696 (2003)
- Moroni G, "The long-term outcome of 93 patients with proliferative lupus nephritis", Nephrol Dial Transplant, 22, pp.2531~2539 (2007)
- Mejía-Vilet JM, "Renal flare prediction and prognosis in lupus nephritis Hispanic patients", Lupus, 25, pp.315~324 (2016)
- Mok CC, "Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis", Arthritis Rheum, 50, pp.2559~2568 (2004)
- Weinmann-Menke J, "Care about the flare : the importance of avoiding lupus nephritis recurrence", Nephrol Dial Transplant, 38, pp.800~802 (2023)
- Perez-Arias AA, "The influence of repeated flares in response to therapy and prognosis in lupus nephritis", Nephrol Dial Transplant, 38, pp.884~893 (2023)
- Moroni G, "Withdrawal of therapy in patients with proliferative lupus nephritis : long-term follow-up", Nephrol Dial Transplant, 21, pp.1541~1548 (2006)
- Yap DYH, "Longterm data on disease flares in patients with proliferative lupus nephritis in recent years", J Rheumatol, 44, pp.1375~1383 (2017)
- Moon SJ, "Predictors of renal relapse in Korean patients with lupus nephritis who achieved remission six months following induction therapy", Lupus, 22, pp.527~537 (2013)
- Ligtenberg G, "Predictors of renal flares and long-term renal outcome in patients with lupus nephritis : results from daily clinical practice", Clin Exp Rheumatol, 40, pp.33~38 (2022)
- Kapsia E, "Predictors of early response, flares, and long-term adverse renal outcomes in proliferative lupus nephritis : a 100-month median follow-up of an inception cohort", J Clin Med, 11, pp.5017~ (2022)
- Isenberg D, "Influence of race", ethnicity on response to lupus nephritis treatment : the ALMS study, 2010, pp.49, 128~140
- Mohan S, "Geographical variation in the response of lupus nephritis to mycophenolate mofetil induction therapy", Clin Nephrol, 75, pp.233~241 (2011)
- Fanouriakis A, "2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association(EULAR", ERA-EDTA)recommendations for the management of lupus nephritis, 2020, pp.79, 713~723
- Hochberg MC, "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 40, pp.1725~ (1997)
- Moroni G, "Lack of EULAR", ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis, 2020, pp.79, 1077~1083
- Gatta A, "Hypoalbuminemia", Intern Emerg Med, 7(Suppl 3), pp.S193~S199 (2012)
- Churg J, "Renal Disease : Classification and Atlas of Glomerular Diseases" (1982), Igaku-Shoin
- Weening JJ, "The classification of glomerulonephritis in systemic lupus erythematosus revisited", Kidney Int, 65, pp.521~530 (2004)
- Austin HA 3rd, "Prognostic factors in lupus nephritis. Contribution of renal histologic data", Am J Med, 75, pp.382~391 (1983)
- Illei GG, "Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy : long-term followup of a cohort of 145 patients participating in randomized controlled studies", Arthritis Rheum, 46, pp.995~1002 (2002)
- Chen YE, "Value of a complete or partial remission in severe lupus nephritis", Clin J Am Soc Nephrol, 3, pp.46~53 (2008)
- So MW, "Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis : a retrospective analysis", Clin Rheumatol, 30, pp.1399~1405 (2011)
- Boumpas DT, "Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis", Lancet, 340, pp.741~745 (1992)
- Ciruelo E, "Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide", Arthritis Rheum, 39, pp.2028~2034 (1996)
- Houssiau FA, "Immunosuppressive therapy in lupus nephritis : the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide", Arthritis Rheum, 46, pp.2121~2131 (2002)
- Mok CC, "Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine", Arthritis Rheum, 46, pp.1003~1013 (2002)
- Hajji M, "Factors associated with relapse of lupus nephritis : A single center study of 249 cases", Saudi J Kidney Dis Transpl, 28, pp.1349~1355 (2017)
- Barber CE, "Sustained remission of lupus nephritis", Lupus, 15, pp.94~101 (2006)
- Cortés-Hernández J, "Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases", Nephrol Dial Transplant, 25, pp.3939~3948 (2010)
- Suzuki E, "Comparison of renal remission and relapse-free rate in initial-and delayed-onset lupus nephritis", Int J Rheum Dis, 24, pp.1500~1509 (2021)
- Cortés-Hernández J, "Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone", Lupus, 12, pp.287~296 (2003)
- Ioannidis JP, "Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide", Kidney Int, 57, pp.258~264 (2000)
- Kwon OC, "Renal flare in class V lupus nephritis : increased risk in patients with tubulointerstitial lesions", Rheumatol Int, 39, pp.2061~2067 (2019)
- Sprangers B, "Diagnosis and treatment of lupus nephritis flares--an update", Nat Rev Nephrol, 8, pp.709~717 (2012)
- Dooley MA, "Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis", N Engl J Med, 365, pp.1886~1895 (2011)
- Houssiau FA, "Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial", Ann Rheum Dis, 69, pp.2083~2089 (2010)
- Furie R, "Two-year, randomized, controlled trial of belimumab in lupus nephritis", N Engl J Med, 383, pp.1117~1128 (2020)
- Atisha-Fregoso Y, "Phase II randomized trial of rituximab plus cyclophosphamide followed by belimumab for the treatment of lupus nephritis", Arthritis Rheumatol, 73, pp.121~131 (2021)
- Ichinose K, "Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis : a single-center, retrospective cohort study", Lupus, 28, pp.501~509 (2019)
- Ali AY, "The prevalence and causes of non-adherence to immunosuppressive medications in patients with lupus nephritis flares", Curr Rheumatol Rev, 16, pp.245~248 (2020)